ResMed research at ATS 2018 International Conference

New research on the prevalence of and treatments for sleep apnea and chronic obstructive pulmonary disease (COPD), presented and/or sponsored by ResMed at the annual conference of the American Thoracic Society in San Diego, May 18–23, 2018.

May 23, 2018
Studies feature an updated global prevalence of sleep apnea, connected health’s role in increasing therapy adherence, and the economic benefits of an emerging home treatment for COPD
May 22, 2018
- Data from more than 2.6 million sleep apnea patients reveals 75 percent adherence rate when patients are remotely monitored - Separate study shows enrolling in resupply programs increases long-term device usage, and decreases termination rates
May 21, 2018
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects
May 20, 2018
Studies presented at the ATS 2018 International Conference demonstrate that combining home non-invasive ventilation with home oxygen therapy is more cost effective for patients with COPD and reduces risks of mortality and hospital readmission
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798


Receive ResMed news releases when they publish.


ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages